[1]CurrentPatentAssignee:SHANGHAIUNIVERSITYOFENGINEERINGSCIENCES-CN113527237,2021,ALocationinpatent:Paragraph0048;0068;0070-0073;0075
[2]CurrentPatentAssignee:ABBVIEINC-WO2004/92115,2004,A2Locationinpatent:Page76
[3]CurrentPatentAssignee:ABBVIEINC-WO2004/92115,2004,A2Locationinpatent:Page82-83
[1]CurrentPatentAssignee:ABBVIEINC-WO2004/92115,2004,A2Locationinpatent:Page83
[2]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-WO2022/261401,2022,A1Locationinpatent:Paragraph00193
[1]CurrentPatentAssignee:ABBVIEINC;SERVIERMONDE-US2014/249215,2014,A1Locationinpatent:Paragraph0031
[1]CurrentPatentAssignee:SERVIERMONDE-WO2016/36910,2016,A1Locationinpatent:Page/Pagecolumn19
[1]CurrentPatentAssignee:SERVIERMONDE-WO2016/36910,2016,A1Locationinpatent:Page/Pagecolumn19
Title: The therapeutic effect of histone deacetylase inhibitor PCI-24781 on gallbladder carcinoma in BK5.erbB2 mice.
Journal: Journal of hepatology 20120701
Title: Vorinostat in acute myeloid leukemia and myelodysplastic syndromes.
Journal: Expert opinion on investigational drugs 20110201
Title: Deactylase inhibition in myeloproliferative neoplasms.
Journal: Investigational new drugs 20101201
Title: A novel histone deacetylase inhibitor Chidamide induces apoptosis of human colon cancer cells.
Journal: Biochemical and biophysical research communications 20100205
Title: PCI-24781 induces caspase and reactive oxygen species-dependent apoptosis through NF-kappaB mechanisms and is synergistic with bortezomib in lymphoma cells.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20090515
Title: CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo.
Journal: Molecular cancer therapeutics 20060501
Title: Buggy JJ, et al. CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo. Mol Cancer Ther, 2006, 5(5), 1309-1317.
Title: Adimoolam S, et al. HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination. Proc Natl Acad Sci U S A, 2007, 104(49), 19482-19487.
Title: Lopez G, et al. Combining PCI-24781, a novel histone deacetylase inhibitor, with chemotherapy for the treatment of soft tissue sarcoma. Clin Cancer Res, 2009, 15(10), 3472-3483.
